STOK:NASDAQ
Stoke Therapeutics Inc
$25.62
arrow_downward
-1.50%(-0.39) 1D
$25.77
arrow_upward
+0.59% (+0.15)todayPre-market
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STOK...
Open
$26.46
High
$26.46
Low
$25.45
Mkt. cap
1.65B
Avg. vol.
943.99K
Volume
3.33K
52-wk high
$40.22
52-wk low
$20.32
EPS
-$3.36
Beta
1.26
Shares outstanding
64.53M
No. of employees
170
Open
$26.46
High
$26.46
Low
$25.45
Mkt. cap
1.65B
Avg. vol.
943.99K
Volume
3.33K
52-wk high
$40.22
52-wk low
$20.32
EPS
-$3.36
Beta
1.26
Shares outstanding
64.53M
No. of employees
170
News stories
From web sources and news partners
Investing.com Canada
·
1 hour ago
Stoke Therapeutics aligns with FDA on zorevunersen NDA submission By Investing.com
Stock Titan
·
1 hour ago
A Dravet medicine trial will measure changes in four areas of thinking and behavior
AD HOC NEWS
·
3 hours ago
Stoke Therapeutics stock heads into November 3 results below key averages
About Stoke Therapeutics Inc
CEO-
Employees170
Founded2014
HeadquartersBedford, Massachusetts, United States
SectorBiotechnology
Websitestoketherapeutics.com